Brief19

Briefings Archive

Period:
RESEARCH
  • An inflammatory truth about kids getting sick with covid-19. MIS-C rates by race
POLICY
  • States to determine vaccine prioritization, not a federal plan
(Week in Review)
POLICY
  • Highest risk factors with incarceration
  • PPE problems persist. How is the Strategic National Stockpile looking?
  • Numbers don't lie
  • California begins curfew. But will it do anything to slow the spread?
(Week in Review)
RESEARCH
  • Trial of convalescent plasma for covid-19 falls flat, another setback for hyped treatment
  • US pediatric testing results for covid-19: The kids are...just ok. And not immune
RESEARCH
  • We are thinking about test performance all wrong. Here's a better way
POLICY
  • PPE problems persist. How is the Strategic National Stockpile looking?
RESEARCH
  • "Any Given Thursday." How many Americans became asymptomatic transmitters today?
  • Vaccine efficacy versus effectiveness
  • Brief19's Outbreak Data Tracker
RESEARCH
  • Hydroxychloroquine still doesn't work for covid-19 prevention
  • Trial of convalescent plasma for covid-19 falls flat, another setback for hyped treatment
POLICY
  • Highest risk factors with incarceration
RESEARCH
  • Older adults with covid-19 may have delirium as the only presenting symptom
POLICY
  • California begins curfew. But will it do anything to slow the spread?
RESEARCH
  • US pediatric testing results for covid-19: The kids are...just ok. And not immune
  • Oxford/AstraZeneca vaccine 62% or 90% effective against covid-19, depending on dose
POLICY
  • Numbers don't lie
(Week in Review)
POLICY
  • Coronavirus and mass decarceration
  • Pfizer vaccine implementation limitations. Was last week's major announcement actually 'news we can use'? Not if it can't reach you
  • Can you test your way out of a second lockdown? Yes
(Week in Review)
RESEARCH
  • Moderna announces interim covid-19 vaccine data; reports 94.5% effectiveness
  • Remdesivir loses support from the WHO
  • First coronavirus home test granted emergency use authorization
RESEARCH
  • Baricitinib and tocilizumab results by press release and Twitter release?
  • Remdesivir loses support from the WHO
POLICY
  • First coronavirus home test granted emergency use authorization
RESEARCH
  • Randomized clinical trial of mask use in Denmark yields equivocal results
POLICY
  • Can you test your way out of a second lockdown? Yes
RESEARCH
  • New insights on covid-19 susceptibility in obese populations
POLICY
  • Coronavirus and mass decarceration
RESEARCH
  • A note on Moderna
  • Moderna announces interim covid-19 vaccine data; reports 94.5% effectiveness
RESEARCH
  • What happens to patients 60 days after they are hospitalized with covid-19?
POLICY
  • Pfizer vaccine implementation limitations. Was last week's major announcement actually 'news we can use'? Not if it can't reach you
(Week in Review)
POLICY
  • Supreme Court signals that is may uphold Affordable Care Act
  • A third wave of coronavirus infections at the White House
  • A return to record-breaking days
(Week in Review)
RESEARCH
  • Pfizer releases exciting vaccine effectiveness datum. (Datum is the singular of data).
POLICY
  • Two new studies on coronavirus cases in United States military environments
RESEARCH
  • Fluvoxamine shows promise in treating covid-19. Should it? Who cares?
POLICY
  • Utah ramps up restrictions as cases swell
RESEARCH
  • Two new studies on coronavirus cases in United States military environments
POLICY
  • The CDC unveils another change on mask wearing among the general public
RESEARCH
  • Research ruminations: do we need a randomized clinical trial to prove masks are good?
POLICY
  • Supreme Court signals that it may uphold Affordable Care Act
RESEARCH
  • Pfizer releases exciting vaccine effectiveness datum. (Datum is the singular of data)
POLICY
  • A third wave of coronavirus infections at the White House
RESEARCH
  • Drops in coronavirus fatality rates mostly hinge on age, study confirms
POLICY
  • A return to record-breaking days
  • President-elect Joseph R. Biden assembling new coronavirus taskforce
(Week in Review)
POLICY
  • Congress to take up coronavirus relief package in "lame duck" session
  • Doctors respond to baseless accusations on covid-19 billing
  • Herd immunity still over the horizon
  • Trump hints at firing Fauci
(Week in Review)
RESEARCH
  • Clinician perspectives early in the pandemic
  • Household risk of SARS-CoV-2 secondary infection
  • New San Francisco study demonstrates imperfect science of contact tracing
RESEARCH
  • Clinician perspectives early in the pandemic
POLICY
  • Congress to take up coronavirus relief package in "lame duck" session
RESEARCH
  • Can we attend concerts again?
POLICY
  • Physicians are less likely to vote compared to the general population professions
RESEARCH
  • Can the prick of a finger produce enough blood for a reliable coronavirus antibody test?
POLICY
  • Doctors respond to baseless accusations on covid-19 billing
RESEARCH
  • Household risk of SARS-CoV-2 secondary infection
POLICY
  • Trump hints at firing Fauci
RESEARCH
  • New San Francisco study demonstrates imperfect science of contact tracing
POLICY
  • Herd immunity still over the horizon
(Week in Review)
POLICY
  • New analysis: 130,000-210,000 United States coronavirus deaths were avoidable
  • Final vaccine rollout recommendations from National Academies of Science
  • Perspective: compounding crises abound in the United States
Past weekJun 2021May 2021Apr 2021Mar 2021Feb 2021Jan 2021Dec 2020Nov 2020Oct 2020Sep 2020Aug 2020Jul 2020Jun 2020May 2020Apr 2020Mar 2020